Anhydrovinblastine
N/A
Report date: 2022/12/08 17:49:12
NME
Base Information
Drug NameAnhydrovinblastine
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPno Resources
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesPno ResourcesRoswell Park Cancer InstituteKeryx Biopharmaceuticals Inc
Active IndicationsN/A
Inactive Indications